Efficient transgene regulation from a single tetracycline-controlled positive feedback regulatory system

Area of Science:

• Molecular Biology
• Gene Therapy
• Biotechnology

Background:

• Precise control of eukaryotic gene expression is crucial for therapeutic applications, requiring vectors with high induced and low basal transgene expression.
• Existing systems often necessitate multiple vectors or lack sufficient regulatory range for effective gene delivery and modulation.

Purpose of the Study:

• To investigate self-contained vectors for controlled gene expression, focusing on a positive feedback regulatory system (PFRS).
• To evaluate the efficacy of a novel enhancerless vector (pSiaIV) for achieving high transgene induction and low basal expression.

Main Methods:

• Transient transfection studies in HeLa cells using self-contained vectors encoding tetracycline-controlled transactivator (tTA) and mGM-CSF.
• Evaluation of an enhancerless positive feedback regulatory vector (pSiaIV) with a modified tTA-responsive bidirectional promoter.
• Comparison of pSiaIV performance against co-transfection methods and assessment in stable cell lines.

Main Results:

• The pSiaIV vector demonstrated over 200-fold gene regulation in HeLa cells, comparable to co-transfection systems.
• Maximal transcriptional activity of pSiaIV rivaled the CMV IE promoter, with basal activity as low as typical tetracycline-responsive promoters (tRP).
• Efficient regulation (47- to 328-fold) was observed across various cell lines and in stable cell models.

Conclusions:

• The positive feedback regulatory system (PFRS) provides efficient and tunable gene regulation suitable for diverse applications.
• The pSiaIV vector offers a promising self-contained solution for precise gene expression control, particularly beneficial for gene therapy.
• This system enhances the potential for modulating therapeutic gene product levels effectively and safely.